Cargando…
Tablet allergen immunotherapy (TAIT) requires tight management
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798371/ https://www.ncbi.nlm.nih.gov/pubmed/33457185 http://dx.doi.org/10.1007/s40629-020-00159-x |
| _version_ | 1783635047023116288 |
|---|---|
| author | Ciprandi, Giorgio |
| author_facet | Ciprandi, Giorgio |
| author_sort | Ciprandi, Giorgio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7798371 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Medizin |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77983712021-01-11 Tablet allergen immunotherapy (TAIT) requires tight management Ciprandi, Giorgio Allergo J Int Letter to the Editor Springer Medizin 2021-01-11 2021 /pmc/articles/PMC7798371/ /pubmed/33457185 http://dx.doi.org/10.1007/s40629-020-00159-x Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Ciprandi, Giorgio Tablet allergen immunotherapy (TAIT) requires tight management |
| title | Tablet allergen immunotherapy (TAIT) requires tight management |
| title_full | Tablet allergen immunotherapy (TAIT) requires tight management |
| title_fullStr | Tablet allergen immunotherapy (TAIT) requires tight management |
| title_full_unstemmed | Tablet allergen immunotherapy (TAIT) requires tight management |
| title_short | Tablet allergen immunotherapy (TAIT) requires tight management |
| title_sort | tablet allergen immunotherapy (tait) requires tight management |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798371/ https://www.ncbi.nlm.nih.gov/pubmed/33457185 http://dx.doi.org/10.1007/s40629-020-00159-x |
| work_keys_str_mv | AT ciprandigiorgio tabletallergenimmunotherapytaitrequirestightmanagement |